Comparative assessment of five serum antimüllerian hormone assays for the diagnosis of polycystic ovary syndrome.
Explore this paper's citation graph
Summary
Performance of the different AMH assays for PCOS diagnosis is comparable, providing that different threshold values are used for manual and automatic assays, as well as a robust tool for the definition of PCOM.
- Type
- article
- Published
- 2016-04-01
- Cited by
- 93
- References
- 24
- Access
- Open access
- OpenAlex
- https://openalex.org/W2226959762
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:31074166
Keywords
Polycystic ovary, Hyperandrogenism, Medicine, Asymptomatic, Anti-Müllerian hormone
References
- Understanding Bland Altman analysis
- Two new automated, compared with two enzyme-linked immunosorbent, antimüllerian hormone assays.
- Performance of the two new fully automated anti-Müllerian hormone immunoassays compared with the clinical standard assay.
- Ultrasound examination of polycystic ovaries: is it worth counting the follicles?
- Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.
- Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool.
- Falsely elevated serum antimüllerian hormone level in a context of heterophilic interference.
- Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
- Ovarian response biomarkers: physiology and performance
- Application of statistical procedures in analytical instrument testing
- First fully automated immunoassay for anti-Müllerian hormone
- Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome.
- Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data.
- Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries.
- Human blood contains both the uncleaved precursor of anti-Mullerian hormone and a complex of the NH2- and COOH-terminal peptides.
- Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.
- Pre-mixing serum samples with assay buffer is a prerequisite for reproducible anti-Mullerian hormone measurement using the Beckman Coulter Gen II assay.
- Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.
- The physiology and clinical utility of anti-Mullerian hormone in women.
- Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).
Cited by
- Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome
- Diagnostic criteria for PCOS: Is there a need for a rethink?
- New automated antimüllerian hormone assays are more reliable than the manual assay in patients with reduced antral follicle count.
- Hyperandrogenism, menstrual irregularities and polycystic ovary syndrome : impact on female reproductive and metabolic health from early adulthood until menopause
- Comparative evaluation of three new commercial immunoassays for anti-Müllerian hormone measurement.
- Anti‐Müllerian hormone reflects the severity of polycystic ovary syndrome
- Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
- Is the understanding of AMH being confounded by study designs that do not adequately reflect that it is an atypical hormone?
- Serum reproductive hormone levels and ultrasound findings in female offspring after intracytoplasmic sperm injection: first results.
- Anti-Müllerian hormone concentrations and parity in fertile women: the model of oocyte donors.
- Relationship between serum anti-Mullerian hormone and clinical parameters in polycystic ovary syndrome.
- Elevated anti‐Mullerian hormone in lean women may not indicate polycystic ovarian syndrome
- Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis
- Non-equivalence of anti-Müllerian hormone automated assays—clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing
- Age‐stratified thresholds of anti‐Müllerian hormone improve prediction of polycystic ovary syndrome over a population‐based threshold
- Significant correlation between anti-müllerian hormone and embryo euploidy in a subpopulation of infertile patients.
- Les hormones sexuelles : comment les doser et quelles performances en clinique ?☆
- Age‐stratified thresholds of anti‐Müllerian hormone improve prediction of polycystic ovary syndrome over a population‐based threshold
- Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Reproductive Age Women
- Efficacy of predictive models for polycystic ovary syndrome using serum levels of two antimüllerian hormone isoforms (proAMH and AMHN,C).
Related papers
- Phenotypic Variation of Polycystic Ovary Syndrome
- Polycystic ovary syndrome and acne.
- Clinical expression of polycystic ovary syndrome in adolescent girls.
- NORMOANDROGENIC VERSUS HYPERANDROGENIC WOMEN WITH POLYCYSTIC OVARY SYNDROME AND THEIR METABOLIC AND CARDIOVASCULAR PROFILE LATER IN LIFE
- Current aspects of polycystic ovary syndrome: A literature review.
- The diagnosis of polycystic ovary syndrome in adolescents.
- Cardiometabolic Risks in Polycystic Ovary Syndrome: Non-Traditional Risk Factors and the Impact of Obesity
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.
- Is Polycystic Ovary Syndrome Another Risk Factor for Venous Thromboembolism? United States, 2003–2008